The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Ipilimumab

Back to Details
This is a "connection" page, showing publications Kenneth S. Cohen has written about Ipilimumab.
Kenneth S. Cohen
Connection Strength
0.221
Ipilimumab
  1. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908. Neuro Oncol. 2023 08 03; 25(8):1530-1545.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.